2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3-Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3-Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)
复制标题
DOI：
10.4155/bio-2019-0271
复制
发表时间：
2019-12-01
期刊：
影响因子：
1.8
通讯作者：
Yang，Tong-Yuan
中科院分区：
文献类型：
--
作者：
Piccoli，Steven;Mehta，Devangi;Yang，Tong-Yuan
影响因子：
--
作者：
Swanson BN
通讯作者：
Swanson BN